The Urokinase/PAI-2 Complex (Q57372452)

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Structure of a serpin-protease complex shows inhibition by deformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Interaction between the P14 residue and strand 2 of beta-sheet B is critical for reactive center loop insertion in plasminogen activator inhibitor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The urokinase plasminogen activator system: role in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

213Bi-PAI2 conjugate selectively induces apoptosis in PC3 metastatic prostate cancer cell line and shows anti-cancer activity in a xenograft animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

In vitro cytotoxicity of bismuth-213 (213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Preclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The urokinase-type plasminogen activator system in cancer metastasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Identification of a binding site in protease nexin I (PN1) required for the receptor mediated internalization of PN1-thrombin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Diverse roles for the LDL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The crystal structure of plasminogen activator inhibitor 2 at 2.0 A resolution: implications for serpin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The topology of plasminogen binding and activation on the surface of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low Density lipoprotein receptor-related protein in caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The low-density lipoprotein receptor-related protein-1 associates transiently with lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

LRP: a multifunctional scavenger and signaling receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200

Endocytosed transferrin receptors recycle via distinct dynamin and phosphatidylinositol 3-kinase-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M513645200